 [21] 
  In sum, I believe that the Federal Court of Appeal’s decision of Atlantic Engraving dictates that the availability of evidence is an additional factor that must be considered as part of the test for granting leave to file additional affidavit material. While Pfizer submits that such a factor does not apply to PM(NOC) proceedings, in my view the availability of evidence plays an important role in safeguarding the legislative intent, which Prothonotary Tabib accurately described as being “that NOC proceedings should be summary in nature and proceeded with expeditiously”.